AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,648 Cr | ₹4,209 Cr | ₹3,743 Cr | ₹3,341 Cr | ₹2,890 Cr |
What is the latest Revenue of AJANTA PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹4,648 Cr |
| Mar2025 | ₹4,209 Cr |
| Mar2024 | ₹3,743 Cr |
| Mar2023 | ₹3,341 Cr |
| Mar2022 | ₹2,890 Cr |
How is Revenue of AJANTA PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,648 Cr | 10.44 | |
| Mar2025 | ₹4,209 Cr | 12.45 | |
| Mar2024 | ₹3,743 Cr | 12.02 | |
| Mar2023 | ₹3,341 Cr | 15.62 | |
| Mar2022 | ₹2,890 Cr | - | |
Compare Revenue of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹42,637.5 Cr | -2.2% | -4.8% | 43.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -2.2% |
-4.8% |
43.1% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses